Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,100 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
The most recent EPS for Agilent Technologies Inc is $1.36, not beating expectations of $1.39.
How did Agilent Technologies Inc A's revenue perform in the last quarter?
Agilent Technologies Inc revenue for the last quarter is $1.36
What is the revenue estimate for Agilent Technologies Inc?
According to 18 of Wall street analyst, the revenue estimate of Agilent Technologies Inc range from $1.91B to $1.75B
What's the earning quality score for Agilent Technologies Inc?
Agilent Technologies Inc has a earning quality score of A/75. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Agilent Technologies Inc report earnings?
Agilent Technologies Inc next earnings report is expected in 2026-05-26
What are Agilent Technologies Inc's expected earnings?
Agilent Technologies Inc expected earnings is $1.84B, according to wall-street analysts.
Did Agilent Technologies Inc beat earnings expectations?
Agilent Technologies Inc recent earnings of $1.79B does not beat expectations.